Co-Authors
This is a "connection" page, showing publications co-authored by Andrew Piper-Vallillo and Paul Hesketh.
Connection Strength
0.238
-
Aglan M, Spyropoulous E, Oster J, Hesketh PJ, Piper-Vallillo AJ. Safety and efficacy of osimertinib 160 mg daily given concurrently with a strong CYP3A4 inducer. Respir Med Case Rep. 2025; 55:102200.
Score: 0.238
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.